Publicaciones en colaboración con investigadores/as de Universidad de Navarra (17)

2022

  1. In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria

    Molecular Therapy - Methods and Clinical Development, Vol. 25, pp. 137-146

  2. Sex-Related Signaling of Aldosterone/Mineralocorticoid Receptor Pathway in Calcific Aortic Stenosis

    Hypertension, Vol. 79, Núm. 8, pp. 1724-1737

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31

2019

  1. Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene.

    Stem Cell Research, Vol. 41

2018

  1. CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I

    Nature Communications, Vol. 9, Núm. 1

2016

  1. Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation

    Stem Cell Research, Vol. 16, Núm. 1, pp. 116-119

2013

  1. The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis

    Critical Care, Vol. 17, Núm. 3

2010

  1. Goal-directed and habitual control in the basal ganglia: Implications for Parkinson's disease

    Nature Reviews Neuroscience, Vol. 11, Núm. 11, pp. 760-772

2006

  1. 'Functional' neuroanatomical tract tracing: Analysis of changes in gene expression of brain circuits of interest

    Brain Research, Vol. 1072, Núm. 1, pp. 91-98

  2. Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats

    European Journal of Neuroscience, Vol. 23, Núm. 8, pp. 2099-2108

2005

  1. Optimization of use of levodopa in Parkinson's disease: Role of levodopa-carbidopa-entacapone combination

    Neurologia, Vol. 20, Núm. 4, pp. 180-188

2001

  1. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: Similarities with cell loss in Parkinson's disease

    Experimental Neurology, Vol. 169, Núm. 1, pp. 163-181

  2. The subthalamic nucleus in Parkinson's disease: Somatotopic organization and physiological characteristics

    Brain, Vol. 124, Núm. 9, pp. 1777-1790

2000

  1. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: Problems with the current model

    Annals of Neurology

1997

  1. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations

    Genes Chromosomes and Cancer, Vol. 18, Núm. 2, pp. 84-93

1996

  1. Origen materno de los cromosomas X en un varón con cariotipo 48,XXYY

    Acta pediátrica española